No Association between Patient Demographics and Adverse Effects of Low-Dose Oral Minoxidil in a Retrospective Cohort study of Nonscarring Alopecia Patients
Keywords:
minoxidil, alopecia, hair lossReferences
Gupta AK, Talukder M, Shemer A, Piraccini BM, Tosti A. Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review. Skin Appendage Disord. 2023;9(6):423-437. DOI:10.1159/000531890. PMID: 38376087; PMCID: PMC10806356.
Ong MM, Do H, Ho B, Lipner SR. Gender Differences in Adverse Effects and Dosing Practices of Low-Dose Oral Minoxidil for Androgenetic Alopecia: A Retrospective Analysis of 310 Patients. Skin Appendage Disord. 2025;11(3):227-231. DOI:10.1159/000542630. PMID: 40475096; PMCID: PMC12136553.
Sanabria B, Vanzela TN, Miot HA, Müller Ramos P. Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients. J Am Acad Dermatol. 2021;84(4):1175-1178. DOI:10.1016/j.jaad.2020.11.035. PMID: 33253848.
Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, et al. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651. DOI:10.1016/j.jaad.2021.02.054. PMID: 33639244.
Penha MA, Miot HA, Kasprzak M, Müller Ramos P. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial. JAMA Dermatol. 2024;160(6):600-605. DOI:10.1001/jamadermatol.2024.0284. PMID: 38598226; PMCID: PMC11007651.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Alexa Podolsky, Shari Lipner
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
